Business Wire

JAMPRO

Share
Jamaica Attracts Diverse Jobs in the Outsourcing Sector

Global outsourcing powerhouse, ibex , is increasing the diversity of jobs within Jamaica’s global digital services industry through an expansion of its current workforce of two thousand employees. The company provides customer support in sectors that include retail, finance, healthcare, and telecommunications, and it now offers a broad spectrum of business services from its Jamaican service centres.

With a client list heavily concentrated in the US, Europe, and Asia, ibex identified Jamaica as the perfect place for rapid expansion due to the island’s location and high-quality talent.

“ibex has experienced incredible growth in Jamaica - in the last three years we’ve grown 397%,” Country Director Jaime Vergara revealed. “We have gone from ranking as the 17th outsourcing company on the island for number of employees to number one, and ibex has been recognized for not only our growth, but for our performance, by organisations like Frost & Sullivan, a leading industry analyst group, and as Nexus Nearshore BPO of the Year in 2019 by Nearshore Americas.”

The high-calibre staff ibex has attracted has cleared the way for it to bring more business to Jamaica’s outsourcing industry and it now offers Knowledge Process Outsourcing (KPO) services from the island’s service centres. KPO is the outsourcing of information-related business activities such as accounting outsourcing, human resources (HR) outsourcing, digital marketing and management consultancy. Legal, medical and other healthcare analyses are additional examples of KPO.

As the world further relies on BPO and KPO during the COVID-19 pandemic, it is predicted that more business services will be digitised during and after the crisis. This and other factors will increase the demand for outsourcing, creating the environment for ibex to safely execute its growth plans both in Jamaica, and globally.

“We plan on prolonging our unprecedented growth and we hope to reach 10,000 employees in Jamaica over the next few years,” Vergara disclosed.

With the specialised skills needed for KPO, Vergara said Jamaica was the perfect location for ibex to offer these services. “Jamaica offers a talented and educated labour pool which is what has made us attractive to our clients, particularly in the financial services sector,” he said. “Through programs like the GSSP (Global Services Sector Project), the employees we hire are on a career path and are looking for companies to join where they can be successful. They are eager to work with their customers in their specialised area.”

Vergara also expressed appreciation for private and public sector partnerships including entities such as the Office of the Prime Minister, the Jamaica Special Economic Zone Authority (JSEZA) and the Jamaica Promotions Corporation (JAMPRO) among others.

JAMPRO, for example, has supported ibex as an investment facilitation partner, beginning with the launch of the first service centre in Portmore. The company now has five service centres across Jamaica.

ibex believes that its advancement into KPO has led to increased customer confidence, displaying the company’s adaptation to the needs of today’s clients. The company looks forward to more expansion in Jamaica.

ABOUT JAMPRO

The Jamaica Promotions Corporation (JAMPRO)’s mission is to drive economic development through growth in investment and export. JAMPRO is an Agency of the Ministry of Industry, Investment, and Commerce.

For more information on JAMPRO, please visit https://dobusinessjamaica.com/ .

Follow us on:
Twitter
Facebook
Instagram
LinkedIn

Link:

ClickThru

Social Media:

https://www.facebook.com/jamprocorp

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 07:00:00 CEST | Press release

Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t

Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay18.9.2025 07:00:00 CEST | Press release

Cetaphil's new Skin Activator Hydrating & Firming Line harnesses a proprietary formula, co-created with dermatologists and offering targeted, high-performance skincare designed to improve the appearance of skin affected by dermatoporosis The line’s new Skin Activator technology uses microdosed alpha hydroxy acid (AHA) and encapsulated centella asiatica (CICA) to wake up sleeping surface skin cells To help bring this segment-defining product line to life, Cetaphil is partnering with acclaimed actress, director, and advocate, Mariska Hargitay, a powerful voice in embracing beauty at every stage Galderma today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is redefining daily skincare with its new Skin Activator Hydrating & Firming line. The launch marks an entirely new skincare segment of advanced hydration and firming solutions designed specifically for improving the appearance of aging, thinning, and fragile skin. As people age, surface

Merck Opens Climate-Neutral €150 Million Filter Manufacturing Facility in Ireland18.9.2025 07:00:00 CEST | Press release

Part of company’s €440 million investment in Ireland, strengthens Merck’s in-region-for-region supply resilienceMerck’s first climate-neutral manufacturing facility, powered by 100 percent renewable electricityNew Blarney site in Cork, Ireland expands filter manufacturing capacity, creating more than 200 jobs by 2028 Merck, a leading science and technology company, has opened today its €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland. The site is Merck’s first manufacturing facility designed for full climate-neutral operations, marking a key milestone in the company’s ambition to achieve climate neutrality by 2040. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917767425/en/ Merck's new Blarney site in Cork expands company's filter capacity, creating 200+ jobs by 2028 The 3,000-square-meter cleanroom facility supports global demand for critical filtration products used in the manufacturin

Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)17.9.2025 21:46:00 CEST | Press release

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Commission (EC) has approved ROMVIMZA™ (vimseltinib) in the European Union (EU) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability1. “The European Commission’s approval of vimseltinib for TGCT is a significant milestone for Deciphera, ONO, and TGCT patients across the European Union who are in need of a non-invasive treatment option. We are excited to leverage our global commercial infrastructure to bring vimseltinib to these patients,” said Ryota Udagawa, President and Chief Executive Officer of Deciphera. “We look forward to worki

Northern Escape Heli-Skiing Sees Global Surge in Demand as Adventurers Seek Canada’s Legendary Powder17.9.2025 18:09:00 CEST | Press release

Luxury adventure travel continues accelerating, with analysts projecting ~7.6% annual growth through 2030 [1][5]. Meanwhile, global tourism reached record highs in 2024 [2], and ski tourism is above pre-pandemic norms [3]. Northern Escape Heli-Skiing (NEH), named World’s Best Heli-Ski Operator by the World Ski Awards [4] in 2022, 2023, and 2024, continues to welcome a truly international mix of guests each winter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909723150/en/ Global Appeal Post-pandemic travellers prioritize remote, nature-led adventures and privacy-forward itineraries [1][3]. Adventure tourism is on a sharp upswing globally [5], while research highlights how social media and influencer content accelerate demand for marquee mountain experiences [7]. At the same time, heli-sports are forecast to expand steadily across Canada, Europe, APAC, and South America [8]. World’s Best Heli-Ski NEH operates in BC’s Ske

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye